ABCC4 and pancreatic neoplasm: Studies currently in progress, involving evaluation of MRP4 protein levels and subcellular localization by immunostaining in PDAC tissue microarrays will further validate MRP4 as an indicator predictor of clinical outcome in pancreatic cancer.